Trademark Search  /  MYLUNG CONSORTIUM

MYLUNG CONSORTIUM

● Live · Registered

U.S. federal trademark · Serial No. 90508673 · Reg. No. 6777452

Mark
MYLUNG CONSORTIUM
Status
Registered
Serial Number
90508673
Registration No.
6777452
Filing Date
February 3, 2021
Registration Date
July 5, 2022
Class(es)
Class 009, Class 035, Class 042, Class 044

Owners

McKesson Corporation
03 · Irving, TX, US
McKesson Corporation
03 · Irving, TX, US
McKesson Corporation
03 · Irving, TX, US

Goods & Services

Healthcare services, namely, collection of data and information on research, testing, diagnosis, and treatment of lung cancer for treatment and diagnostic purposes; Providing medical informational services for the purpose of raising awareness, and disseminating best practices for the testing, diagnosis, and treatment of lung cancer

Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures featuring information on research, testing, diagnosis, and treatment for lung cancer

Business management, business administration, and office function services in the nature of the facilitation and management of the collection, tracking, and maintenance of data relating to the testing, diagnosis, and treatment of lung cancer from medical providers, patients, medical researchers, and medical, biopharmaceutical, and biotechnology companies; business administration and office function services in the nature of the coordinating the collection, compilation, tracking, and maintenance of information and data relating to the testing, diagnosis, and treatment of lung cancer; Market intelligence services, namely, providing therapeutic insights and benchmarking information to stakeholders in the fields of medicine and healthcare; Promoting collaboration within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Promoting the exchange of information within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Providing information for the development of best practices for the testing, diagnosis, and treatment of lung cancer

Research services, namely, organizing collaborative research and development of protocols regarding the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing collaboration in medical research and data collection around the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing genomic, medical, biomedical and health care related research regarding lung cancer for medical research purposes; Providing medical research information in the field of lung cancer; Providing medical and scientific research information in the field of lung cancer

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "MYLUNG CONSORTIUM" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.